Overwhelming diffuse psoriasis during chronic HCV infection, after peginterferon-ribavirin treatment, supported by frequent resort to filgrastim rescue

Braz J Infect Dis. 2010 Jul-Aug;14(4):327.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antiviral Agents / administration & dosage
  • Antiviral Agents / adverse effects*
  • Drug Therapy, Combination
  • Female
  • Filgrastim
  • Granulocyte Colony-Stimulating Factor / administration & dosage
  • Granulocyte Colony-Stimulating Factor / adverse effects*
  • Hepatitis C, Chronic / drug therapy
  • Humans
  • Interferon Type I / administration & dosage
  • Interferon Type I / adverse effects*
  • Interferon alpha-2
  • Interferon-alpha / adverse effects
  • Polyethylene Glycols / adverse effects
  • Psoriasis / chemically induced*
  • Recombinant Proteins
  • Ribavirin / administration & dosage
  • Ribavirin / adverse effects*

Substances

  • Antiviral Agents
  • Interferon Type I
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor
  • Polyethylene Glycols
  • Ribavirin
  • Filgrastim
  • peginterferon alfa-2a